About Index Trending news
Analyze
Pricing
Delinia

Delinia

Work at Delinia? Add yourself to this profile

Delinia

Delinia aims to discover and develop novel therapeutics targeting regulatory T cells for the treatment of autoimmune and inflammatory diseases

Elsewhere

Alexa global traffic share

Twitter followers

Acquired by
26 Jan 2017
Celgene Corporation
$300,000,000
3
Latest funding
Venture capital (Series A)
$35,000,000
Locations
HQ
$300,000,000
GEN , Xconomy , businesswire

Celgene Buys Delinia for $300M to Acquire Treg Therapy for Autoimmune Diseases Genetic Engineering & Biotechnology News - Biotech from Bench to Business

$35,000,000 Venture capital (Series A)
businesswire , FinSMEs

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases | Business Wire